Pierre Major

Zoledronic Acid Is Superior to Pamidronate in the Treatment of Hypercalcemia of Malignancy: A Pooled Analysis of Two Randomized, Controlled Clinical Trials

Pierre Major, Alain Lortholary, Jeremy K. Hon et al. · Journal of Clinical Oncology · 2001 · 857 citations

Medicine, Pharmacology, Pharmacotherapy +10

Radiation with or without Antiandrogen Therapy in Recurrent Prostate Cancer

William U. Shipley, Wendy Seiferheld, Himanshu Lukka et al. · New England Journal of Medicine · 2017 · 662 citations · Full text

Medicine, Oncology, Urology +16

Bone Turnover Markers as Predictors of Skeletal Complications in Prostate Cancer, Lung Cancer, and Other Solid Tumors

J. E. Brown, Richard J. Cook, Pierre Major et al. · JNCI Journal of the National Cancer Institute · 2005 · 564 citations · Full text

Medicine, Biostatistics, Oncology +16

Predictive Value of Bone Resorption and Formation Markers in Cancer Patients With Bone Metastases Receiving the Bisphosphonate Zoledronic Acid

Robert E. Coleman, Pierre Major, Allan Lipton et al. · Journal of Clinical Oncology · 2005 · 531 citations · Full text

Medicine, Oncology, Bone Metabolism +16

Correlation of cytotoxicity with incorporation of ara-C into DNA.

Donald Küfe, Pierre Major, E.Michael Egan et al. · Journal of Biological Chemistry · 1980 · 362 citations · Full text

Pharmacy, Biochemistry, Molecular Biology +13